About

Feifan Ouyang is a prominent electrophysiologist whose research has significantly advanced the field of catheter ablation for atrial fibrillation (AF), with a particular focus on robotic navigation systems and pulmonary vein isolation (PVI). Working at the intersection of cardiac electrophysiology and emerging technologies, Ouyang has been instrumental in evaluating the safety, efficacy, and clinical utility of robotic-assisted ablation compared to conventional manual techniques. Among his most impactful contributions is his early identification of the unexpectedly high incidence of esophageal injury associated with robotic navigation during PVI (89 citations), a critical safety finding that shaped clinical practice worldwide. His 2009 study on remote robotic navigation and electroanatomical mapping (74 citations) helped establish foundational methodology in the field, while his 2012 worldwide multicenter survey of robotic ablation outcomes (66 citations) provided the largest collective evidence base at the time. Ouyang also led the rigorous Man and Machine Trial, a prospective international study directly comparing manual and robotic ablation approaches, culminating in key findings published in 2017. Notably, he performed the first in-human robotic rotor ablation for AF in 2014, demonstrating his commitment to pioneering innovation in cardiac electrophysiology.

Research Focus

Key Achievements

10
H-Index
12
Papers
391
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Unexpected High Incidence of Esophageal Injury Following Pulmonary Vein Isolation Using Robotic Navigation
89 citations · 2010
📈 Most Prolific Year: 2010 (2 Papers)
🤝 Key Collaborators: 61
🏛 Institutions: Institute of Cardiology, Asklepios Klinik St. Georg, Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago